Cargando…
Tangential headwinds when integrating industry‐funded clinical trials into a US health care delivery system
Although there are regulatory obligations put forth by the US Food and Drug Administration (FDA) that directly govern clinical trials and other investigational therapies, such activity does not occur in a vacuum. There are other regulations and administrative policies that are tangential to the oper...
Autor principal: | Vulcano, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6508756/ https://www.ncbi.nlm.nih.gov/pubmed/31245597 http://dx.doi.org/10.1002/lrh2.10075 |
Ejemplares similares
-
Organizing the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST): National Institutes of Health, Health Care Financing Administration, and industry funding
por: Hobson, Robert W, et al.
Publicado: (2001) -
Use and abuse of statistics in tobacco industry-funded research on standardised packaging
por: Laverty, Anthony A, et al.
Publicado: (2015) -
Specialty Pharmaceuticals Care Management in an Integrated Health Care Delivery System with Electronic Health Records
por: Monroe, C. Douglas, et al.
Publicado: (2013) -
HIV/AIDS: global trends, global funds and delivery bottlenecks
por: Coovadia, Hoosen M, et al.
Publicado: (2005) -
Public funding and private investment for R&D: a survey in China’s pharmaceutical industry
por: Qiu, Lan, et al.
Publicado: (2014)